Permira agreed to invest in Thoma Bravo-backed Motus, a reimbursement software platform. Financial terms were not disclosed. The deal, which is subject to customary regulatory approvals, is expected to close in the fourth quarter of 2021. "Motus has been a really special investment for us given the business transformation work undertaken in combining Motus and Runzheimer years ago. The company's strategy, team, growth rate and new product investment are all higher than ever, and we are even more excited for the future here, particularly with a terrific partner like Permira," A.J. Rohde, Thoma Bravo Senior Partner.